Page last updated: 2024-08-25

oxazolidin-2-one and Anthrax

oxazolidin-2-one has been researched along with Anthrax in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abshire, T; Brown, DL; Drusano, GL; Heine, HS; Holman, K; Kulawy, R; Liu, W; Louie, A; Vanscoy, BD	1
Brown, DL; Drusano, GL; Heine, HS; Kim, K; Kinzig-Schippers, M; Liu, W; Louie, A; Sörgel, F; VanScoy, B	1

Other Studies

2 other study(ies) available for oxazolidin-2-one and Anthrax

Article	Year
Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Acetamides; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacterial Load; Bacterial Toxins; Ciprofloxacin; Diffusion Chambers, Culture; Infusion Pumps; Linezolid; Microbial Sensitivity Tests; Models, Biological; Oxazolidinones; Spores, Bacterial	2012
Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracis. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Acetamides; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Linezolid; Models, Biological; Monte Carlo Method; Mutation; Oxazolidinones	2008

Article

Year

Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system.

Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

Topics: Acetamides; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacterial Load; Bacterial Toxins; Ciprofloxacin; Diffusion Chambers, Culture; Infusion Pumps; Linezolid; Microbial Sensitivity Tests; Models, Biological; Oxazolidinones; Spores, Bacterial

2012

Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracis.

Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

Topics: Acetamides; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Linezolid; Models, Biological; Monte Carlo Method; Mutation; Oxazolidinones

2008